【结 构 式】 |
【分子编号】64826 【品名】(1S)-1-(chloromethyl)-2,3-dihydro-1H-benzo[e]indol-5-ol 【CA登记号】 |
【 分 子 式 】C13H12ClNO 【 分 子 量 】233.69712 【元素组成】C 66.81% H 5.18% Cl 15.17% N 5.99% O 6.85% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(XIII)Cleavage of the trichloroethyl ester of (X) using Zn/HCO2H gives the carboxylic acid (XI). The N-Boc benzindole derivative (XII) is deprotected under acidic conditions to the amine (XIII), which is subsequently coupled with acid (XI) to yield the amide (XIV). Finally, palladium catalyzed cleavage of the N-Alloc group of (XIV) with concomitant dehydration leads to the desired compound.
【1】 Tercel, M.; Stribbling, S.M.; Sheppard, H.; Siim, B.G.; Wu, K.; Pullen, S.M.; Botting, K.J.; Wilson, W.R.; Denny, W.A.; Unsymmetrical DNA cross-linking agents: Combination of the CBI and PBD pharmacophores. J Med Chem 2003, 46, 11, 2132. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 64823 | allyl (11aS)-11-hydroxy-7-methoxy-5-oxo-8-{[6-oxo-6-(2,2,2-trichloroethoxy)hexyl]oxy}-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate | C25H31Cl3N2O8 | 详情 | 详情 | |
(XI) | 64824 | 6-({(11aS)-10-[(allyloxy)carbonyl]-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl}oxy)hexanoic acid | C23H30N2O8 | 详情 | 详情 | |
(XII) | 64825 | tert-butyl (1S)-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benzo[e]indole-3-carboxylate | C18H20ClNO3 | 详情 | 详情 | |
(XIII) | 64826 | (1S)-1-(chloromethyl)-2,3-dihydro-1H-benzo[e]indol-5-ol | C13H12ClNO | 详情 | 详情 | |
(XIV) | 64827 | allyl (11aS)-8-({6-[(1S)-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benzo[e]indol-3-yl]-6-oxohexyl}oxy)-11-hydroxy-7-methoxy-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate | C36H40ClN3O8 | 详情 | 详情 |
Extended Information